Header Logo

Connection

Mayer Davidson to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Clinical Trials, Phase III as Topic.
Mayer Davidson
Connection Strength
0.216
Clinical Trials, Phase III as Topic
  1. In adults with BMI =27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2023 11; 176(11):JC129.
    View in: PubMed
    Score: 0.216
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.